我的購物車 (0)
我的帳號資料
我的訂單紀錄
我的學校教授
我的學校課程

[ Tips ] 一分鐘使用導覽

搜尋 
請輸入欲查詢之關鍵字
 
  進階搜尋
依主題瀏覽 
依商品類型瀏覽 
依出版日期瀏覽 
依作者瀏覽(姓) 
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
V
W
Y
Z
銷售排行榜 
 您所選取的商品項目

> Anagene, Inc.

商品編號: 9-102-030
出版日期: 2001/10/01
作者姓名:
Kaplan, Robert S.;Darwall, Christina
商品類別: Other
商品規格: 17p

再版日期: 2008/03/13
地域: California
產業: Biotechnology
個案年度: 2001 -  2001

 


商品敘述:

An entrepreneurial, publicly traded biotech company has begun production and sales of its core product--cartridges that permit DNA samples to be analyzed on a microchip. In the early quarters, sales are difficult to forecast and the company has experienced fluctuating production volumes and unpredictable gross margins, which has upset the board of directors. The finance staff investigates whether to adopt a new costing approach based on capacity. With large amounts of unused capacity, the decision of how to apply capacity costs is critical to the company''s management and its reporting strategy with analysts.


涵蓋領域:

Management accounting;Cost accounting;Capacity analysis


相關資料:

Case Teaching Note, (5-102-078), 12p, by Robert S. Kaplan;
Spreadsheet Supplement, (XLS008), 0p, by Robert S. Kaplan, Christina Darwall